Patient-centric drug product development: Acceptability across patient populations - Science and evidence.

Stegemann, Sven; Klingmann, Viviane; Reidemeister, Sibylle; Breitkreutz, Jörg

Stegemann, Sven; Klingmann, Viviane; Reidemeister, Sibylle; Breitkreutz, Jörg.

Afiliação

Stegemann S; Leibniz JointLab First in Translation, Forckenbeckstrasse 50, 52074 Aachen, Germany. Electronic address: stegemann@dwi.rwth-aachen.de.
Klingmann V; University Hospital Düsseldorf, Department of General Paediatrics, Neonatology and Paediatric Cardiology , Moorenstrasse 5, 40225 Düsseldorf, Germany.
Reidemeister S; Novartis, Global Drug Development/Technical Research & Development, Novartis Campus, 4056 Basel, Switzerland.
Breitkreutz J; University of Düsseldorf, Institute of Pharmaceutical Technology and Biopharmacy, Universitätsstrasse 1, 40225 Düsseldorf, Germany.

Eur J Pharm Biopharm ; 188: 1-5, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37164232

Assuntos

Desenho de Fármacos; Tecnologia Farmacêutica; Humanos; Desenvolvimento de Medicamentos; Assistência Centrada no Paciente

Palavras-chave

Acceptability; Drug product design; Methodology; Patient engagement; Patient-centric; Regulation; Reimbursement

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Tecnologia Farmacêutica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google